These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 17662471)

  • 1. ROC analysis of dexamethasone suppression test threshold in suicide prediction after attempted suicide.
    Jokinen J; Nordström AL; Nordström P
    J Affect Disord; 2008 Feb; 106(1-2):145-52. PubMed ID: 17662471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CSF 5-HIAA and DST non-suppression--orthogonal biologic risk factors for suicide in male mood disorder inpatients.
    Jokinen J; Nordström AL; Nordström P
    Psychiatry Res; 2009 Jan; 165(1-2):96-102. PubMed ID: 19062105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dexamethasone suppression test and suicide prediction.
    Coryell W; Schlesser M
    Am J Psychiatry; 2001 May; 158(5):748-53. PubMed ID: 11329397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dexamethasone suppression test as a predictor of suicidal behavior in unipolar depression.
    Yerevanian BI; Feusner JD; Koek RJ; Mintz J
    J Affect Disord; 2004 Dec; 83(2-3):103-8. PubMed ID: 15555702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DST non-suppression predicts suicide after attempted suicide.
    Jokinen J; Carlborg A; Mårtensson B; Forslund K; Nordström AL; Nordström P
    Psychiatry Res; 2007 Apr; 150(3):297-303. PubMed ID: 17316825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HPA axis hyperactivity as suicide predictor in elderly mood disorder inpatients.
    Jokinen J; Nordström P
    Psychoneuroendocrinology; 2008 Nov; 33(10):1387-93. PubMed ID: 18805641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPA axis hyperactivity and attempted suicide in young adult mood disorder inpatients.
    Jokinen J; Nordström P
    J Affect Disord; 2009 Jul; 116(1-2):117-20. PubMed ID: 19054569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dexamethasone suppression test and completed suicide.
    Norman WH; Brown WA; Miller IW; Keitner GI; Overholser JC
    Acta Psychiatr Scand; 1990 Feb; 81(2):120-5. PubMed ID: 2327273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined biological tests for suicide prediction.
    Coryell W; Schlesser M
    Psychiatry Res; 2007 Mar; 150(2):187-91. PubMed ID: 17289156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPA axis hyperactivity and cardiovascular mortality in mood disorder inpatients.
    Jokinen J; Nordström P
    J Affect Disord; 2009 Jul; 116(1-2):88-92. PubMed ID: 19054568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dexamethasone suppression test in patients with mood disorders.
    Rush AJ; Giles DE; Schlesser MA; Orsulak PJ; Parker CR; Weissenburger JE; Crowley GT; Khatami M; Vasavada N
    J Clin Psychiatry; 1996 Oct; 57(10):470-84. PubMed ID: 8909334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CSF 5-HIAA and DST non-suppression -independent biomarkers in suicide attempters?
    Jokinen J; Mårtensson B; Nordström AL; Nordström P
    J Affect Disord; 2008 Jan; 105(1-3):241-5. PubMed ID: 17499856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative and depressive symptoms in suicidal schizophrenics.
    Jones JS; Stein DJ; Stanley B; Guido JR; Winchel R; Stanley M
    Acta Psychiatr Scand; 1994 Feb; 89(2):81-7. PubMed ID: 8178667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPA-axis hyperactivity and mortality in psychotic depressive disorder: preliminary findings.
    Coryell W; Fiedorowicz J; Zimmerman M; Young E
    Psychoneuroendocrinology; 2008 Jun; 33(5):654-8. PubMed ID: 18378097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasopressin-neurophysin and DST in major depression: relationship with suicidal behavior.
    Pitchot W; Scantamburlo G; Pinto E; Hansenne M; Reggers J; Ansseau M; Legros JJ
    J Psychiatr Res; 2008 Jul; 42(8):684-8. PubMed ID: 17720191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noradrenergic function and HPA axis dysregulation in suicidal behaviour.
    Jokinen J; Ouda J; Nordström P
    Psychoneuroendocrinology; 2010 Nov; 35(10):1536-42. PubMed ID: 20576361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypothalamic-pituitary-adrenal axis hyperactivity is associated with decreased brain-derived neurotrophic factor in female suicide attempters.
    Ambrus L; Lindqvist D; Träskman-Bendz L; Westrin Å
    Nord J Psychiatry; 2016 Nov; 70(8):575-81. PubMed ID: 27216156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attempted suicide predicts suicide risk in mood disorders.
    Nordström P; Asberg M; Aberg-Wistedt A; Nordin C
    Acta Psychiatr Scand; 1995 Nov; 92(5):345-50. PubMed ID: 8619338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Low-dose (0.5 mg) DST in manic and major depressive episodes: in relation to the severity of symptoms].
    Matsunaga H; Sarai M
    Seishin Shinkeigaku Zasshi; 2000; 102(4):367-98. PubMed ID: 10892305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypothalamic-pituitary-adrenal axis function and suicidal behavior in depression.
    Roy A
    Biol Psychiatry; 1992 Nov; 32(9):812-6. PubMed ID: 1450295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.